📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why? (2018)

First Author: Leucht S

Attributed to: MICA: Application for a Mental Health Data Pathfinder award (Oxford) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00406-018-0940-0

PubMed Identifier: 30178421

Publication URI: http://europepmc.org/abstract/MED/30178421

Type: Journal Article/Review

Volume: 268

Parent Publication: European archives of psychiatry and clinical neuroscience

Issue: 7

ISSN: 0940-1334